Skin collagen peptide research in Canada investigates copper tripeptide GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) for its fibroblast-activating, collagen-synthesis-promoting, and dermal repair biology applications. GHK-Cu is a naturally occurring human plasma tripeptide that declines with aging (from approximately 200 ng/mL at age 20 to 80 ng/mL at age 60), and Canadian dermatology research and aging biology groups study it for its ability to activate dermal fibroblasts, induce collagen type I and III synthesis, promote angiogenesis, and modulate wound healing gene expression through TGF-β and SPARC pathways.
Fibroblast Activation and Collagen Research
GHK-Cu activates dermal fibroblasts through copper-dependent enzyme activation (lysyl oxidase, superoxide dismutase) and TGF-β receptor-mediated SMAD2/3 signalling to increase collagen type I, III, and IV synthesis, as well as elastin, fibronectin, and decorin production. Canadian dermatology researchers study GHK-Cu’s fibroblast activation profile using gene expression arrays to characterize the full transcriptomic response of human fibroblasts to GHK-Cu treatment in skin biology research models.
Wound Healing and Angiogenesis Research
GHK-Cu promotes wound healing through VEGF-A upregulation (angiogenesis), keratinocyte migration activation via EGF receptor, and metalloproteinase modulation that remodels provisional matrix. Canadian wound biology researchers use GHK-Cu to study the copper complex-dependent mechanisms of skin repair and the role of endogenous copper-binding peptides in wound biology coordination.
Sourcing GHK-Cu in Canada
Research-grade GHK-Cu is available from EhBuddy Peptides in Canada. Lab-tested for purity. For laboratory research use only.
